ASPIRIN AS A “GOLD STANDARD” IN CARDIOVASCULAR PREVENTION

ASPIRIN AS A “GOLD STANDARD” IN CARDIOVASCULAR PREVENTION

.

Bibliographic Details
Main Author:	S. V. Nedogoda
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2010-06-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1486

Similar Items

Aspirin for prevention of cancer and cardiovascular disease.
by: Rose, P, et al.
Published: (2011)

Role of aspirin in primary prevention of cardiovascular disease
by: Patrono, C, et al.
Published: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
by: VanWormer JJ, et al.
Published: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
by: Ying Xing, et al.
Published: (2019-07-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

Polypills with or without aspirin for primary prevention of cardiovascular disease
by: Mant, J, et al.
Published: (2021)

Aspirin use for cardiovascular disease prevention in the uninsured population
by: Nina Liu, et al.
Published: (2020-06-01)

Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19
by: Temistocles Diaz, et al.
Published: (2020-11-01)

Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
by: Sylvester KW, et al.
Published: (2013-05-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
by: Price, H, et al.
Published: (2009)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Guillaume Marquis‐Gravel, et al.
Published: (2024-02-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
by: Yinong Chen, et al.
Published: (2021-09-01)

APPLICATION OF CALCIUM ANTAGONISTS IN PREVENTION OF CARDIOVASCULAR COMPLICATIONS DURING CARDIAC SURGERY
by: S. V. Nedogoda
Published: (2016-01-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
by: Hennekens, C, et al.
Published: (1989)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
by: Athena L. Huang, et al.
Published: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
by: Athena L. Huang, MD, et al.
Published: (2023-09-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
by: Lozano R, et al.
Published: (2015-07-01)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
by: Nischal N Hegde, et al.
Published: (2023-01-01)

Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis.
by: Inge Stegeman, et al.
Published: (2015-01-01)

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
by: Xie W, et al.
Published: (2019-09-01)

Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease.
by: Ae Jin Kim, et al.
Published: (2014-01-01)

Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease
by: Tzeyu L. Michaud, et al.
Published: (2015-12-01)

Aspirin for thromboembolic complication prevention in cardiovascular disease: dose optimization and adverse effect minimization
by: A. N. Britov
Published: (2006-12-01)

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
by: Tognoni Gianni, et al.
Published: (2007-08-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Published: (2005-12-01)

2019 Chinese expert consensus statement on aspirin application in primary prevention of cardiovascular disease
by: Xiao-Ying Li, et al.
Published: (2020-05-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
by: Randall S Stafford, et al.
Published: (2005-12-01)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
by: Mikkel B. Christensen, et al.
Published: (2021-06-01)

Aspirin in the prevention of cancer Reply
by: Rothwell, P
Published: (2011)

Uso de aspirina en la prevención de enfermedades cardiovasculares Use of aspirin in the prevention of cardiovascular diseases
by: Ronald G García G, et al.
Published: (2008-10-01)

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
by: Georg Gelbenegger, et al.
Published: (2019-11-01)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis.
by: Shuai Tan, et al.
Published: (2015-01-01)

Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative Review
by: Bianca Clerici, et al.
Published: (2023-03-01)

Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification
by: Alberto Aimo, et al.
Published: (2020-01-01)

Aspirin Use to Prevent Cardiovascular Disease in Adults: Interpretation of U.S. Preventive Services Task Force Recommendations Statement
by: LI Mingyan, SHI Weili, DUAN Hongyan
Published: (2024-04-01)

A community-based group randomized trial to increase aspirin use for primary prevention of cardiovascular disease: Study protocol and baseline results for the “Ask About Aspirin” initiative
by: Sue Duval, et al.
Published: (2021-06-01)

Aspirin for primary prevention in patients with high cardiovascular risk: insights from CORE-Thailand registry
by: Wanwarang Wongcharoen, et al.
Published: (2023-09-01)

Older adult preferences regarding benefits and harms of statin and aspirin therapy for cardiovascular primary prevention
by: Frances M. Wang, et al.
Published: (2023-03-01)

Cardiovascular disease preventive effects of aspirin combined with different statins in the United States general population
by: Tao Liu, et al.
Published: (2023-03-01)

Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
by: Hadar Haim-Pinhas, et al.
Published: (2022-10-01)